TETRALOGIC PHARMACEUTICALS CORP Retained Earnings
TETRALOGIC PHARMACEUTICALS CORP had Retained Earnings of -$202.00 million as of 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2016-11-03
- 2016-09-30: Retained Earnings (Accumulated Deficit) -$202.00M.
- 2016-06-30: Retained Earnings (Accumulated Deficit) -$193.37M.
- 2016-03-31: Retained Earnings (Accumulated Deficit) -$186.62M.
- 2015-12-31: Retained Earnings (Accumulated Deficit) -$175.56M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2016-09-30 | -$202.00M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$193.37M 10-Q · filed 2016-08-11 |
| 2016-03-31 | -$186.62M 10-Q · filed 2016-05-04 |
| 2015-12-31 | -$175.56M 10-Q · filed 2016-11-03 |
| 2015-09-30 | -$161.28M 10-Q · filed 2015-11-04 |
| 2015-06-30 | -$150.39M 10-Q · filed 2015-08-05 |
| 2015-03-31 | -$138.51M 10-Q · filed 2015-05-14 |
| 2014-12-31 | -$125.83M 10-K · filed 2016-03-16 |
| 2014-09-30 | -$113.89M 10-Q · filed 2014-11-05 |
| 2014-06-30 | -$104.56M 10-Q · filed 2014-08-05 |
| 2014-03-31 | -$95.21M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$89.87M 10-K · filed 2015-02-26 |